1.Changes of HMGB1 and VE-cadherin in serum of children with viral myocarditis
Min HUA ; Youmin HUANG ; Yongqin ZHOU
Clinical Medicine of China 2011;27(8):880-883
Objective To investigate the changes of high mobility group box-1 ( HMGB1 ) and VE-cadherin in serum of children with viral myocarditis and their clinical significance. Methods The serum levels of HMGB1 and VE-cadherin were detected by ELISA in 52 children with viral myocarditis, and 36 normal healthy children were enrolled as control. CK-MB was also measured in all subjects enrolled into the study. Results The serum levels of HMGB1, VE-cadherin and CK-MB in children with acute stage viral myocarditis (HMGB1 :[5.14 ±0. 23] mg/L;VE-cadherin: [5.36 ±0. 92] mg/L;CK-MB: [31.42 ± 3.22] U/L)were significantly higher than those with recovery stage viral myocarditis ( HMGB1: [ 0. 92 ± 0. 14 ] mg/L, VE-cadherin: [2. 93 ±0. 64] mg/L; CK-MB: [ 13.75 ± 3.18 ] U/L) ( t = 11.37,10. 26 and 12. 17 respectively ,Ps < 0. 01 )and control (HMGB1 :[ 0. 86 ± 0. 12 ] mg/L; VE-cadherin: [ 2. 86 ± 0. 65 ] mg/L; CK-MB: [ 12. 83 ±3.04] U/L) (t = 12.06,11.19 and 12. 64 respectively,Ps <0.01 ). However,we found no significant difference in the serum levels of HMGB1, VE-cadherin and CK-MB between recovery stage viral myocarditis group and the control ( t = 1.26,1.19,1.43, Ps > 0. 05 ). There were positive correlations between HMGB1 and VE-cadherin,CK-MB (r = 0. 73,0. 79, Ps < 0. 05 ) ;and positive correlation between VE-cadherin and CK-MB (r= 0. 82, P <0.05). Conclusion HMGB1 and VE-cadherin may play roles in the viral myocarditis pathogenesis, which can be new prognosis factors for viral myocarditis.
3.Prognostic value of heart rate turbulence in patients with chronic heart failure
Min GAO ; Hua YU ; Ying HUANG ; Weiping XU ; Qun LIANG
Chinese Journal of Geriatrics 2010;29(3):192-194
Objective To investigate the prognostic value of heart rate turbulence (HRT) in patients with chronic heart failure (CHF). Methods From October 2006 to May 2009, a total of 96 elderly CHF inpatients were selected, and the clinic data were recorded. Based on the echocardiogram and dynamic electrocardiogram, the differences of sinus HRT index of patients with different cardiac function classification were analyzed. During 9-28 months medical follow-up, the treatment endpoint was death from heart disease. Based on Logisitc regression, the prognostic values of HRT, age, hypertension, diabetes, myocardial infarction (MI), left ventricular ejection fraction, ACEI and β- adrenergic blocker for death of CHF patients were analyzed.Results There was no significant difference in HRT between grade Ⅱ and grade Ⅲ cardiac function (χ~2 = 1.60, P>0. 05), and between grade Ⅲ and grade Ⅳ cardiac function (χ~2 = 1.43, P>0. 05). But there was significant difference in HRT between grade Ⅱ and grade Ⅳ cardiac function patients χ~2 =9.84, P<0. 05), and HRT was weaken in grade Ⅳ group. The average follow-up time was (18. 0±9.6) months. Of all 96 patients, there were 34 dead of heart disease. There were correlations of death of CHF with HRT, low LVEF (≤ 45%), age (≥65 years), diabetes, MI and classification of heart function. Conclusions The sinus HRT in CHF patients has a favorable prognostic value.
6.Evaluation on Efficacy and Safety of Jinying Capsule in Treatment of Pelvic Inflammatory Disease Patients with Accumulated Damp-heat Syndrome.
Qin LI ; Chun-yan CHEN ; Yu-ping SUO ; Min HUANG ; Xian-hua HUANG
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(12):1459-1462
OBJECTIVETo evaluate the efficacy and safety of Jinying Capsule (JC) in treating pelvic inflammatory disease patients with accumulated damp-heat syndrome (ADHS).
METHODSTotally 328 patients were recruited in a prospective, positive drug parallel controlled, and multi-center clinical trial. Of them 213 patients in the treatment group took JC (0.5 g per capsule), 4 capsules each time, 3 times per day, while 115 patients in the control group took Kangfuyan Capsule (KC, 0.4 g per capsule), 3 capsules each time, twice per day. The course of treatment was 4 weeks for all. Scores of Chinese medical syndromes, visual analogue scale (VAS) of the lower abdominal pain, and European quality of life-five dimension scale (EQ-5D) were observed before treatment and after 4 weeks of treatment.
RESULTSThere were 204 patients in the treatment group and 109 in the control group who completed this trial. The total effective rate of Chinese medical syndrome was 89.71% (183/204 cases) in the treatment group and 76.15% (83/109 cases) in the control group (P < 0.01). Compared with before treatment in the same group, EQ-5D scores increased, and VAS scores of the lower abdominal pain decreased in the two groups after treatment. EQ-5D scores was 0.857 ± 0.157 in the treatment group, obviously higher than that in the control group (0.753 ± 0.126, P < 0.05). VAS scores of the lower abdominal pain was 2.14 ± 1.23 in the treatment group, lower than that in the control group (2.33 ± 1.24), but with no statistical difference between the two groups (P > 0.05). No adverse reaction occurred in the two groups.
CONCLUSIONJC was superior to KC in improving Chinese medical syndrome and quality of life of pelvic inflammatory disease patients with accumulated damp-heat syndrome.
Capsules ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Hot Temperature ; Humans ; Medicine, Chinese Traditional ; Pelvic Inflammatory Disease ; drug therapy ; Phytotherapy ; Prospective Studies ; Quality of Life ; Safety ; Syndrome
7.Appraisal of the repair gastroschisis with autogenous umbilical cord
Hua HUANG ; Guangjun HOU ; Leipeng SHAO ; Xionjie GENG ; Erhua ZHANG ; Xianliang WANG ; Lin QI ; Min HUANG
Chinese Journal of Postgraduates of Medicine 2009;32(9):15-17
Objective To review the treatment of repair gastroschisis with autogenous umbilical cord and evaluate its effect. Methods Thirty newborns who underwent the repair gastroschisis with autogenous umbilical cord between August 1992 to October 2007, 26 cases survived under observed and followed-up, observing physical growth, intelligence measuring and whether the area of operated in abdomen need staged repair or not. Compared with 15 cases who underwent traditional operation method at the same time. Results Two cases died, 2 cases abandoned, and 26 ease received survive (survive rate 86.7%)and their growth was well in 26 cases. But in those 15 cases who underwent traditional operation method, 5 cases survived (survive rate 33.3%). There were significant difference in the survive rate, the mean operative time and postoperative hospital stay time between the two operation methods (P <0.05).Conclusion The material is adopted easily in the operation, autogenous umbilical cord is elastic tissue and no toxicity, it can relax the abdominal press effectively after the operation, the survive rate is high.
10.Clinical observation of fengbei huayu recipe in treating diabetic nephropathy.
Wei-hua CAO ; Li-hong HUANG ; Min GUO
Chinese Journal of Integrated Traditional and Western Medicine 2005;25(11):1022-1024
OBJECTIVETo study the effects of Fengbei Huayu recipe (FHR) on urinary albumin excretion rate (UAER) in patients with diabetic nephropathy (DN).
METHODSSeventy-two type 2 DN patients in III or IV stage were randomly divided into two groups, 36 in each group. All patients were treated with conventional hypoglycemic agents and hypotensor, but those in the treated group were given additionally with FHR twice a day for 8 successive weeks. The changes of UAER, D-polymer, glycosylate hemoglobin (HbA1c), renal function indexes, including blood urea nitrogen (BUN) and serum creatinine (SCr), and blood lipids, including total cholesterol (TC) and triglyceride (TG) in the two groups before and after treatment were compared.
RESULTSThe levels of UAER, D-polymer, HbA1c, TC and TG were significantly decreased after treatment in the treat- ed group (P < 0.05), and the improvement were superior to those in the control group (P <0.05) respectively. But the difference of renal function before and after treatment showed no significance in both groups.
CONCLUSIONFHR could not only obviously decrease the level of UAER, but also decrease the levels of blood glucose and blood-lipids in patients with DN.
Adult ; Aged ; Albuminuria ; drug therapy ; Diabetes Mellitus, Type 2 ; drug therapy ; Diabetic Nephropathies ; drug therapy ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Hypoglycemic Agents ; therapeutic use ; Male ; Middle Aged ; Phytotherapy